Condition / Condition Gynecology

Endometriosis and Infertility

Endometriosis is an estrogen-dependent, inflammatory condition in which endometrium-like tissue grows outside the uterus, affecting roughly 10% of reproductive-age women. Infertility, defined as failure to conceive after 12 months of unprotected intercourse (6 months if ≥35 years), co-occurs frequently with endometriosis. Among infertile women, endometriosis is found in about 25–50%, and 30–50% of women with endometriosis experience subfertility at some point. The relationship is multifactorial: endometriosis can distort pelvic anatomy, form adhesions and endometriomas, alter tubal function, and create an inflammatory peritoneal environment that impairs sperm function, oocyte quality, fertilization, and embryo implantation. At the uterine level, progesterone resistance and impaired endometrial receptivity are well-described. In the ovary, endometriomas and their surgical treatment can reduce ovarian reserve. Diagnosis is often delayed, and severity (ASRM stages I–IV) does not perfectly predict fertility impact. Minimal/mild disease can still reduce fecundability via inflammatory and immunologic mechanisms; conversely, some women with advanced disease conceive spontaneously. Clinical management balances symptom control and fertility goals. Medical suppression with combined hormonal contraceptives, progestins, or GnRH analogues improves pain but does not enhance natural fertility and can delay conception while suppressing ovulation. By contrast, laparoscopic ablation/excision of minimal/mild lesions modestly improves spontaneous pregnancy and live birth compared with diagnostic laparoscopy alone. For moderate/severe disease or after failed expectant management, assisted reproductive technologies (ART) are effective. Controlled ovarian stimulation with intrauterine insemination (IUI) can be considered in minimal/mild disease; in more advanced disease or with tubal/ovarian factors, in vitro fertilization (IVF/ICSI) bypasses peritoneal factors and tubal pathology. For ≥

Updated March 13, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Shared Risk Factors

Genetic predisposition/family history

Moderate Evidence

First-degree relatives of women with endometriosis have a higher risk; infertility shows heritability and shared reproductive trait genetics. Some GWAS suggest overlapping pathways in hormone signaling and inflammation.

Increases endometriosis risk roughly 2–7× in family studies.
Familial subfertility risk is recognized; overlap may be indirect via endometriosis and shared reproductive biology.

Menstrual characteristics (early menarche, short cycles, heavy flow)

Moderate Evidence

Greater lifetime menstrual volume and retrograde menstruation are associated with endometriosis; such patterns may co-occur with dysmenorrhea and dyspareunia that impede timed intercourse and can signal underlying pathology.

Consistently linked to higher endometriosis risk.
Indirect—may reduce fecundability via endometriosis, intercourse avoidance, or anemia; not an independent strong infertility risk factor.

Delayed childbearing/older reproductive age at first pregnancy

Moderate Evidence

Later first pregnancy is associated with endometriosis diagnosis and independently reduces natural fecundity due to age-related decline in ovarian reserve.

Parity appears protective; delayed childbearing correlates with endometriosis prevalence.
Strongly increases infertility risk through age-related mechanisms.

Immune/inflammatory dysregulation

Emerging Research

Endometriosis is characterized by peritoneal macrophage activation, cytokine elevation, and oxidative stress; systemic inflammation has been linked to reduced fecundability.

Core pathophysiology of endometriosis.
Inflammation may impair gamete/embryo function and implantation.

Environmental endocrine-disrupting chemicals (e.g., dioxins, PCBs, phthalates)

Emerging Research

Observational studies associate certain pollutants with higher endometriosis risk and reduced fecundity, though causality is not proven.

Several studies link higher exposures with endometriosis.
Associations with longer time-to-pregnancy and ART outcomes reported.

Extremes of BMI (especially low BMI)

Moderate Evidence

Lower BMI is modestly associated with endometriosis; both underweight and obesity reduce fertility via hormonal and ovulatory effects.

Lower BMI correlated with higher endometriosis prevalence in cohort studies.
Underweight and obesity each reduce fecundability and ART success.

Müllerian anomalies/outflow obstruction

Moderate Evidence

Congenital anomalies and outflow obstruction increase retrograde menstruation and can mechanically reduce fertility.

Higher risk of endometriosis due to retrograde flow.
May directly impair fertility via anatomic factors.

Comorbidity Data

Prevalence

Endometriosis affects ~10% of reproductive-age women; it is present in 25–50% of infertile women. Approximately 30–50% of women with endometriosis experience infertility.

Mechanistic Link

Pelvic inflammation, adhesions, and endometriomas distort anatomy and impair tubal pick-up; altered peritoneal cytokines, oxidative stress, and immune dysfunction reduce sperm motility/function and oocyte/embryo quality. Endometrial progesterone resistance and aberrant receptivity impede implantation; ovarian reserve may decline due to endometriomas and surgical excision.

Clinical Implications

Women with symptoms suggestive of endometriosis who desire pregnancy warrant earlier fertility evaluation (particularly if ≥35 years). Medical suppression alone does not improve natural fertility. Laparoscopic ablation/excision can improve spontaneous conception in minimal/mild disease. For moderate–severe disease, diminished ovarian reserve, advanced age, or after failed expectant/surgical management, ART (IUI in minimal/mild; IVF/ICSI otherwise) is recommended. Endometrioma surgery should be individualized because cystectomy can lower AMH/antral follicle count; consider surgery for pain, suspicion of malignancy, infection risk, or when cysts impede oocyte retrieval.

Sources (3)
  1. ESHRE guideline: Endometriosis (2022), Hum Reprod Open 2022;hoac042
  2. ASRM Practice Committee. Endometriosis and infertility: a committee opinion. Fertil Steril 2012;98:591–8 (with subsequent updates/affirmations)
  3. Vercellini et al. Endometriosis and infertility: pathogenesis and management. Lancet 2014;384:1273–81

Overlapping Treatments

Laparoscopic excision/ablation of endometriosis

Moderate Evidence
Benefits for Endometriosis

Reduces pain, lesions, and adhesions; improves quality of life.

Benefits for Infertility

In minimal/mild disease, increases spontaneous pregnancy/live birth compared with diagnostic laparoscopy alone.

Surgical risks; recurrence possible; benefit less clear in severe disease without concurrent ART.

Endometrioma cystectomy (selected cases)

Moderate Evidence
Benefits for Endometriosis

Reduces pain and recurrence versus drainage/ablation; allows histology.

Benefits for Infertility

May improve spontaneous conception by restoring anatomy.

Can reduce ovarian reserve (AMH/AFC); for IVF, avoid routine removal of asymptomatic <4 cm cysts; individualize.

Assisted reproductive technologies (IUI/IVF/ICSI)

Strong Evidence
Benefits for Endometriosis

Bypasses peritoneal inflammation and distorted anatomy to achieve pregnancy; may reduce need for repeated surgery.

Benefits for Infertility

Effective for endometriosis-associated infertility; IVF/ICSI offers highest success in moderate–severe disease or diminished reserve.

Costs, access, and procedural risks; pretreatment strategies debated; endometriomas may increase retrieval risks.

Pelvic floor physical therapy

Moderate Evidence
Benefits for Endometriosis

Improves dyspareunia and pelvic floor dysfunction common in endometriosis.

Benefits for Infertility

May increase comfort with intercourse and adherence to timed intercourse; indirect fertility benefit.

Direct effects on fecundability not well quantified.

Anti-inflammatory lifestyle (balanced diet, exercise, sleep, stress reduction)

Emerging Research
Benefits for Endometriosis

May reduce systemic inflammation and pain flares.

Benefits for Infertility

Supports ovulation and general reproductive health; may improve ART readiness.

Adjunctive, not a replacement for medical/surgical/ART care.

Omega-3 fatty acids

Emerging Research
Benefits for Endometriosis

May reduce dysmenorrhea and inflammatory markers.

Benefits for Infertility

Possible support to oocyte/embryo quality via anti-inflammatory effects.

Heterogeneous data; modest effect sizes.

Acupuncture (adjunct)

Emerging Research
Benefits for Endometriosis

Can reduce pelvic pain and dysmenorrhea for some patients.

Benefits for Infertility

Evidence for improved fertility outcomes is mixed/uncertain; may aid stress reduction during ART.

Does not replace evidence-based fertility treatments; select qualified practitioners.

Medical Perspectives

Western Perspective

Western medicine recognizes endometriosis as a chronic, estrogen-driven inflammatory disease that can impair fertility through anatomic distortion, peritoneal immune dysregulation, altered endometrial receptivity, and potential compromise of ovarian reserve. Management is stratified by age, disease stage, pain, ovarian reserve, and duration of infertility, aiming to maximize cumulative live birth while minimizing harm to ovarian tissue and avoiding unnecessary delays.

Key Insights

  • Endometriosis increases infertility risk; severity does not perfectly predict fecundability.
  • Medical suppression improves pain but does not improve spontaneous conception; avoid delaying attempts to conceive when pregnancy is the goal.
  • Laparoscopic ablation/excision modestly improves natural conception in minimal/mild disease.
  • IUI with controlled ovarian stimulation can be considered for minimal/mild disease; IVF/ICSI is preferred for moderate–severe disease, diminished ovarian reserve, or age ≥35.
  • Endometrioma surgery should be individualized due to ovarian reserve risks; routine pre-IVF cystectomy is not recommended unless clinically indicated.
  • GnRH agonist pretreatment before IVF may improve outcomes in some cases, but evidence is mixed and practice varies.

Treatments

  • Diagnostic and therapeutic laparoscopy (excision/ablation, adhesiolysis)
  • IUI with ovarian stimulation (minimal/mild disease)
  • IVF/ICSI for moderate–severe disease or after failed expectant/surgical management
  • Targeted endometrioma management balancing pain relief and ovarian reserve
  • Adjuncts: pain-directed pharmacotherapy, pelvic floor PT, nutrition/exercise counseling
Evidence: Strong Evidence

Sources

  • ESHRE guideline: Endometriosis (2022), Hum Reprod Open 2022;hoac042
  • Jacobson et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane 2014
  • Hamdan et al. IVF outcomes in women with endometriosis. Reprod Biomed Online 2015
  • Somigliana et al. Ovarian reserve after endometrioma surgery. Hum Reprod Update 2012
  • ASRM Practice Committee. Endometriosis and infertility: a committee opinion. Fertil Steril 2012 (updates)

Eastern Perspective

In Traditional Chinese Medicine (TCM), endometriosis corresponds to patterns such as blood stasis, cold in the uterus, liver qi stagnation, and phlegm-damp accumulation; infertility often reflects kidney deficiency with concurrent blood stasis or liver qi stagnation. The shared pathogenesis is impaired flow of qi and blood in the Chong and Ren channels, leading to dysmenorrhea, pelvic masses, and difficulty conceiving.

Key Insights

  • Treating blood stasis and harmonizing liver qi are central to easing pain and promoting conception.
  • Warming the uterus (moxibustion) and tonifying kidney qi may improve endometrial receptivity from a TCM perspective.
  • Acupuncture and individualized herbal formulas are used to reduce pain, regulate cycles, and support fertility, often as adjuncts to ART.
  • Evidence suggests benefits for pain and quality of life; fertility outcomes remain uncertain with heterogeneous study quality.

Treatments

  • Acupuncture protocols often including SP6, LR3, CV4, ST29, Zigong; peri-ovulatory modulation; adjunctive use around embryo transfer
  • Moxibustion and warming techniques for cold-type dysmenorrhea
  • Herbal formulas tailored to pattern, e.g., Shao Fu Zhu Yu Tang (blood stasis/cold), Gui Zhi Fu Ling Wan (blood stasis), Wen Jing Tang (deficiency-cold), with modifications
  • Dietary therapy emphasizing warm, easily digested foods; stress reduction and gentle movement (qigong/taichi)
Evidence: Moderate Evidence

Sources

  • Flower A et al. Chinese herbal medicine for endometriosis. Cochrane 2012 (limited/low-certainty evidence)
  • Smith CA et al. Acupuncture for IVF/ICSI outcomes. Cochrane 2019 (little to no effect on live birth)
  • WHO Traditional Medicine Strategy 2014–2023 (contextual)
  • Contemporary TCM gynecology texts on blood stasis and infertility patterns

Evidence Ratings

Endometriosis increases the risk of infertility.

ASRM Practice Committee 2012/updates; ESHRE Guideline 2022

Strong Evidence

Medical suppression alone (e.g., OCPs, progestins, GnRH analogues) does not improve natural fertility.

ESHRE Guideline 2022; ASRM Committee Opinions

Strong Evidence

Laparoscopic ablation/excision of minimal/mild endometriosis improves spontaneous pregnancy/live birth compared with diagnostic laparoscopy alone.

Cochrane Review 2014 (Jacobson et al.)

Moderate Evidence

IUI with controlled ovarian stimulation benefits some couples with minimal/mild endometriosis.

ESHRE Guideline 2022; ASRM guidance

Moderate Evidence

IVF/ICSI is effective for endometriosis-associated infertility and often preferred in moderate–severe disease or with diminished ovarian reserve.

ESHRE Guideline 2022; Hamdan et al. 2015 meta-analysis

Strong Evidence

Endometrioma cystectomy may reduce ovarian reserve (AMH/AFC decline).

Somigliana et al. Hum Reprod Update 2012; ESHRE 2022

Strong Evidence

GnRH agonist pretreatment for 2–3 months before IVF may improve outcomes in endometriosis.

Sallam et al. meta-analysis; ESHRE 2022 (conditional)

Moderate Evidence

Acupuncture reduces endometriosis-related pain for some patients, but fertility benefits are uncertain.

Cochrane 2019 (Smith et al. IVF acupuncture: little/no live-birth effect); small RCTs for pain

Emerging Research

Environmental endocrine disruptors contribute to risk of both endometriosis and reduced fecundity.

Epidemiologic studies (e.g., ENDO study 2013); evidence not yet causal

Emerging Research

Western Medicine Perspective

From a Western clinical standpoint, endometriosis and infertility are tightly linked through inflammatory and structural mechanisms. Even minimal or mild peritoneal disease can impair fecundability by exposing gametes and embryos to cytokine-rich peritoneal fluid and reactive oxygen species while altering endometrial receptivity via progesterone resistance. With advancing disease, adhesions and endometriomas distort tubal-ovarian relationships and hinder ovum pickup. Surgical treatment is most helpful when tailored: in minimal/mild disease, ablation or excision can modestly increase spontaneous conception and may precede limited cycles of controlled ovarian stimulation with IUI. In moderate to severe disease—or when age, duration of infertility, or ovarian reserve argues against delay—IVF/ICSI efficiently bypasses peritoneal factors and anatomic barriers. Endometriomas present a dilemma: cystectomy may relieve pain and facilitate natural conception but can reduce ovarian reserve; routine pre-IVF removal is avoided unless cysts are large, symptomatic, or suspicious. Medical suppression alleviates pain yet does not promote natural conception and should not delay fertility-directed care. Shared decision-making should integrate patient age, symptom burden, prior surgery, ovarian reserve (AMH/AFC), and the couple’s preferences and timeline. Adjunctive measures—pelvic floor physical therapy, smoking cessation, exercise, and nutrition—can support overall outcomes but should complement, not replace, evidence-based reproductive treatments.

Eastern Medicine Perspective

In TCM, the coexistence of endometriosis and infertility is interpreted as a disturbance of qi and blood flow in the reproductive channels. Chronic blood stasis underlies fixed pelvic pain and masses; kidney deficiency lessens reproductive vitality; liver qi stagnation impairs the smooth flow essential for ovulation and implantation; and cold in the uterus can obstruct conception. Treatment aims to move blood, soothe the liver, warm and tonify the kidney, and thereby harmonize the cycle. Acupuncture at points such as SP6, LR3, CV4, ST29, and Zigong is used cyclically and around ART procedures to ease pain, regulate menses, and reduce stress, while moxibustion warms cold-type patterns. Classical herbal formulas—such as Shao Fu Zhu Yu Tang for cold-stasis pain or Gui Zhi Fu Ling Wan for blood stasis—are individualized to signs. Modern studies suggest symptom improvement and quality-of-life gains, with uncertain but possible adjunctive benefits for fertility, especially when integrated with ART. Practically, patients who value TCM may consider it as a supportive therapy alongside guideline-based fertility care, ensuring coordination with reproductive specialists to avoid herb–drug interactions and to maintain a timely pathway to conception, particularly for women over 35 or with diminished ovarian reserve.

Sources
  1. ESHRE guideline: Endometriosis (2022), Hum Reprod Open 2022;hoac042
  2. ASRM Practice Committee. Endometriosis and infertility: a committee opinion. Fertil Steril 2012;98:591–8 (with updates)
  3. Jacobson TZ et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2014
  4. Hamdan M et al. The impact of endometriosis on IVF/ICSI outcomes. Reprod Biomed Online 2015
  5. Somigliana E et al. The effect of endometrioma surgery on ovarian reserve. Hum Reprod Update 2012
  6. Smith CA et al. Acupuncture for IVF/ICSI. Cochrane Database Syst Rev 2019
  7. Flower A et al. Chinese herbal medicine for endometriosis. Cochrane Database Syst Rev 2012
  8. Vercellini P et al. Endometriosis and infertility. Lancet 2014

Related Topics

Recommended Products

It Starts with the Egg: How the Science of Egg Quality Can Help You Get Pregnant Naturally, Prevent Miscarriage, and Improve Your Odds in IVF: Fett, Rebecca
book

It Starts with the Egg: How the Science of Egg Quality Can Help You Get Pregnant Naturally, Prevent Miscarriage, and Improve Your Odds in IVF: Fett, Rebecca

&quot;Rebecca Fett&#x27;s first edition of &#x27;It Starts with the Egg&#x27; <strong>revolutionized the way the fertility community viewed supplements and the impact of environmental toxins on reprod

Jarrow Formulas QH-absorb 200 mg - High Absorption Co-Q10 - Active Antioxidant Form of Co-Q10 - Supports Mitochondrial Energy Production &Cardiovascular Health - Up to 60 Servings
supplement

Jarrow Formulas QH-absorb 200 mg - High Absorption Co-Q10 - Active Antioxidant Form of Co-Q10 - Supports Mitochondrial Energy Production &Cardiovascular Health - Up to 60 Servings

60 SOFTGELS FOR 60 DAYS: Start a new routine with Jarrow QH-Absorb; This co q 10 200mg supplements <strong>offers a 60-day supply of coq10 to support healthy cardiovascular function</strong> (1) ... J

Life Extension N-Acetyl-L-Cysteine (NAC), Immune, Respiratory, Liver Health, NAC 600 mg, Potent antioxidant Support, Free-radicals, Easy to Absorb, 60 Capsules
supplement

Life Extension N-Acetyl-L-Cysteine (NAC), Immune, Respiratory, Liver Health, NAC 600 mg, Potent antioxidant Support, Free-radicals, Easy to Absorb, 60 Capsules

<strong>Each NAC capsule delivers 600 mg of this powerful, rapidly absorbed nutrient</strong>. NAC is a powerful free radical scavenger and helps you combat everyday oxidative stress. NAC replenishes

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.